免疫受病毒性癌症的影响——综述

生命科学研究 Pub Date : 2014-11-24 DOI:10.2875/.V1I1.5
Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel
{"title":"免疫受病毒性癌症的影响——综述","authors":"Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel","doi":"10.2875/.V1I1.5","DOIUrl":null,"url":null,"abstract":"ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.","PeriodicalId":18198,"journal":{"name":"生命科学研究","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunity is Affected by Viral Cancer- A Review\",\"authors\":\"Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel\",\"doi\":\"10.2875/.V1I1.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.\",\"PeriodicalId\":18198,\"journal\":{\"name\":\"生命科学研究\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"生命科学研究\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2875/.V1I1.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"生命科学研究","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2875/.V1I1.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

T细胞反应识别和根除癌细胞。然而,T细胞消灭癌症只是癌症-免疫循环的一个步骤,它管理着自我识别和预防自身免疫之间的微妙平衡。癌细胞T细胞抑制信号的识别,包括pd - l1,促进了一类新的癌症免疫疗法的发展,这种疗法可以特异性地阻碍免疫效应抑制,重新激活并潜在地扩大先前存在的抗癌免疫反应。肿瘤微环境中抑制因子的存在可能解释了以前基于免疫的治疗所观察到的有限活性,以及为什么这些治疗与靶向周期其他步骤的药物联合使用可能更有效。新出现的临床数据表明,肿瘤免疫治疗很可能成为肿瘤临床管理的关键部分。关键词:免疫,病毒,肿瘤,人乳头瘤病毒,治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Immunity is Affected by Viral Cancer- A Review
ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
2529
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信